Author

S. O'Leary

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:benchmarking· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:database / resource· 1 Research Focus:drug response / drug discovery· 1 Assay:electrophysiology· 1 Organism:mouse· 1 Organism:non-human primate· 1

Frequent Co-Authors

A. Dhuliyawalla· 1 shared A. K. Thotakura· 1 shared A. K. Wakhloo· 1 shared A. Robledo· 1 shared D. Melvin· 1 shared E. Oelmann· 1 shared E. Pring· 1 shared E. Taggart· 1 shared

Activity by Year

2019-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

A. Dhuliyawalla

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Endocisternal interfaces for minimally invasive neural stimulation and recording of the brain and spinal cord

J. C. Chen, A. Dhuliyawalla, R. Garcia, A. Robledo, J. E. Woods, F. Alrashdan, S. O'Leary, S. Crosby, M. M. Felicella, A. K. Wakhloo, P. Karas, W. Goodman, S. A. Sheth, S. A. Sheth, J. Robinson, P. Kan

This paper introduces a chronic endocisternal neural interface for minimally invasive brain and spinal cord stimulation and recording, demonstrating repositioning and explantation capabilities in a large animal model.

bioRxiv · Oct 12, 2023Bioengineering

A novel antibody targeting ICOS increases intratumoural cytotoxic to regulatory T cell ratio and induces tumour regression.

R. C. A. Sainson, A. K. Thotakura, M. Kosmac, G. Borhis, N. Parveen, R. Kimber, J. Carvalho, S. Henderson, K. Pryke, T. Okell, S. O'Leary, S. Ball, L. Gamand, E. Taggart, E. Pring, , M. McCourt

This paper develops an antibody targeting ICOS that improves the TEFF:TReg ratio and induces tumour regression in preclinical models.

bioRxiv · Sep 16, 2019 · PreprintCancer Biology